Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 11
25
Diseases
79
Unique genes
0.317
Avg. similarity score
Collagenopathy
Most-connected disease (18 links)
Disease
Searched: platyspondylic dysplasia, Torrance type
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
platyspondylic dysplasia, Torrance type
Collagenopathy
Coxa plana
Czech dysplasia
Dysspondyloenchondromatosis
kniest dysplasia
Congenital hip dysplasia
Avascular necrosis of femoral head
Rhegmatogenous retinal detachment
Vitreoretinopathy
COL2A1-related spondyloepiphyseal dysplasia
Otospondylomegaepiphyseal dysplasia
Stickler syndrome type 1
Synovitis
dysplasia of the proximal femoral epiphyses
spondyloperipheral dysplasia
Chondrosarcoma
Maffucci syndrome
Eye disorder
Synovial sarcoma
Beukes hip dysplasia
GNPTAB-mucolipidosis
Hip dislocation-facial dysmorphism syndrome
Neovascular inflammatory vitreoretinopathy
Sarcoma
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Collagenopathy | 18 | 18 | 1 |
| Coxa plana | 18 | 18 | 1 |
| Czech dysplasia | 17 | 17 | 1 |
| Dysspondyloenchondromatosis | 17 | 17 | 1 |
| kniest dysplasia | 14 | 14 | 1 |
| Congenital hip dysplasia | 7 | 7 | 5 |
| Avascular necrosis of femoral head | 6 | 6 | 3 |
| Rhegmatogenous retinal detachment | 6 | 6 | 7 |
| Vitreoretinopathy | 6 | 6 | 3 |
| COL2A1-related spondyloepiphyseal dysplasia | 5 | 5 | 1 |
| Otospondylomegaepiphyseal dysplasia | 5 | 5 | 2 |
| Stickler syndrome type 1 | 5 | 5 | 1 |
| Synovitis | 5 | 5 | 9 |
| dysplasia of the proximal femoral epiphyses | 5 | 5 | 1 |
| platyspondylic dysplasia, Torrance type | 5 | 5 | 1 |
| spondyloperipheral dysplasia | 5 | 5 | 1 |
| Chondrosarcoma | 4 | 4 | 9 |
| Maffucci syndrome | 4 | 4 | 9 |
| Eye disorder | 3 | 3 | 10 |
| Synovial sarcoma | 2 | 2 | 3 |
| Beukes hip dysplasia | 1 | 1 | 1 |
| GNPTAB-mucolipidosis | 1 | 1 | 1 |
| Hip dislocation-facial dysmorphism syndrome | 1 | 1 | 1 |
| Neovascular inflammatory vitreoretinopathy | 1 | 1 | 1 |
| Sarcoma | 1 | 1 | 33 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL2A1 | 19 / 25 | Avascular necrosis of femoral head, Chondrosarcoma, COL2A1-related spondyloepiphyseal dysplasia, Collagenopathy and 15 more |
| SS18 | 3 / 25 | Rhegmatogenous retinal detachment, Sarcoma, Synovial sarcoma |
| BCL2 | 2 / 25 | Chondrosarcoma, Sarcoma |
| CAPN5 | 2 / 25 | Neovascular inflammatory vitreoretinopathy, Vitreoretinopathy |
| GNPTAB | 2 / 25 | Avascular necrosis of femoral head, GNPTAB-mucolipidosis |
| POMC | 2 / 25 | Eye disorder, Synovitis |
| SSX1 | 2 / 25 | Sarcoma, Synovial sarcoma |
| SSX2 | 2 / 25 | Sarcoma, Synovial sarcoma |
| TRIM33 | 2 / 25 | Congenital hip dysplasia, Hip dislocation-facial dysmorphism syndrome |
| UFSP2 | 2 / 25 | Beukes hip dysplasia, Congenital hip dysplasia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interleukin-4 and Interleukin-13 signaling | Reactome | 12 / 108 | 16.9× | 4.65e-12 | 8.90e-10 ✓ sig. |
| Transcriptional misregulation in cancer | KEGG | 14 / 198 | 10.7× | 3.36e-11 | 5.47e-9 ✓ sig. |
| Cellular senescence | KEGG | 10 / 157 | 9.7× | 7.27e-8 | 5.28e-6 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 11 / 224 | 7.5× | 2.21e-7 | 1.39e-5 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 9 / 141 | 9.7× | 3.36e-7 | 2.02e-5 ✓ sig. |
| Graft-versus-host disease | KEGG | 6 / 45 | 20.3× | 4.44e-7 | 2.57e-5 ✓ sig. |
| Interleukin-10 signaling | Reactome | 6 / 47 | 19.4× | 5.79e-7 | 3.22e-5 ✓ sig. |
| Rheumatoid arthritis | KEGG | 7 / 95 | 11.2× | 2.82e-6 | 1.27e-4 ✓ sig. |
| Herpes simplex virus 1 infection | KEGG | 9 / 182 | 7.5× | 2.86e-6 | 1.29e-4 ✓ sig. |
| African trypanosomiasis | KEGG | 5 / 37 | 20.5× | 4.01e-6 | 1.70e-4 ✓ sig. |
| Inflammatory bowel disease | KEGG | 6 / 66 | 13.8× | 4.44e-6 | 1.85e-4 ✓ sig. |
| Central carbon metabolism in cancer | KEGG | 6 / 71 | 12.8× | 6.81e-6 | 2.60e-4 ✓ sig. |
| Pathways in cancer | KEGG | 14 / 533 | 4.0× | 8.42e-6 | 3.09e-4 ✓ sig. |
| Platinum drug resistance | KEGG | 6 / 75 | 12.2× | 9.38e-6 | 3.36e-4 ✓ sig. |
| p53 signaling pathway | KEGG | 6 / 75 | 12.2× | 9.38e-6 | 3.36e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 26 / 1,208 | 5.1× | 1.71e-12 | 7.53e-10 ✓ sig. |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 7 / 37 | 44.8× | 1.71e-10 | 4.72e-8 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 19 / 778 | 5.8× | 3.97e-10 | 9.93e-8 ✓ sig. |
| vascular endothelial growth factor production | GO:0010573 | 4 / 6 | 158× | 4.41e-9 | 8.29e-7 ✓ sig. |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 6 / 36 | 39.4× | 8.28e-9 | 1.44e-6 ✓ sig. |
| regulation of gene expression | GO:0010468 | 13 / 402 | 7.6× | 1.27e-8 | 2.10e-6 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 14 / 504 | 6.6× | 2.25e-8 | 3.46e-6 ✓ sig. |
| positive regulation of chemokine production | GO:0032722 | 6 / 49 | 29.0× | 5.69e-8 | 7.60e-6 ✓ sig. |
| brain development | GO:0007420 | 10 / 244 | 9.7× | 7.84e-8 | 1.00e-5 ✓ sig. |
| replicative senescence | GO:0090399 | 4 / 16 | 59.1× | 5.18e-7 | 4.94e-5 ✓ sig. |
| positive regulation of neuroinflammatory response | GO:0150078 | 4 / 16 | 59.1× | 5.18e-7 | 4.94e-5 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 17 / 1,002 | 4.0× | 7.49e-7 | 6.70e-5 ✓ sig. |
| positive regulation of apoptotic process | GO:0043065 | 10 / 326 | 7.3× | 1.13e-6 | 9.36e-5 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 8 / 187 | 10.1× | 1.23e-6 | 1.01e-4 ✓ sig. |
| animal organ morphogenesis | GO:0009887 | 7 / 130 | 12.7× | 1.28e-6 | 1.04e-4 ✓ sig. |